Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Accelerating synthetic chemistry with a predictive retrosynthesis solution
Posted on August 12th, 2021 by Ann-Marie Roche in AI & Data
In most aspects of life, we think of “endless possibilities” as a good thing. But in science, the wealth of possibilities can be daunting. Pharmaceutical researchers typically start with a disease that they want to tackle, find a target, and then try to identify compounds which interact with that target. There may be around 200-300 drug candidates per project, and synthesis planning and execution usually takes four to eight weeks per drug candidate. This process requires many chemists and a huge, costly effort to proceed.
(more…)Technology and empathy help make remote working a success for Elsevier
Posted on July 29th, 2021 by Ann-Marie Roche in Pharma R&D
We at Elsevier were pleased to be one of five companies recognized for their ability to keep remote workers rooted in company culture in this recent Comparably article. Like many organizations during the pandemic, we had to quickly adapt to remote working on a large scale for our international workforce. As the article notes, “Elsevier took an empathetic and pragmatic approach in supporting its people and its customers and rapidly harnessed technology to work from home.”
(more…)Expert Forum Examines the Patent Content Expansion Plan for Reaxys
Posted on May 21st, 2021 by Anja Brunner in Chemistry
User feedback is instrumental to the evolution of Reaxys. Not only in articulating what works and what is missing, but also in guiding the direction of newly developed capabilities to meet user information needs.
(more…)Competitive Intelligence Gets a Boost with Reaxys Patent Expansion
Posted on April 30th, 2021 by Ann-Marie Roche in Chemistry
The insights only found in patents can provide a crucial competitive advantage for innovative companies. In response to customer demand, Elsevier recently announced a major expansion of the patent content available to users of Reaxys, our chemistry information solution. Users can now get relevant patents for pharma and chemical R&D from 105 patent offices and 170 IPC classes. This also includes English language translations of foreign-language patents, which is important given that scientific advances are being made every day all across the globe.
(more…)
